Verena Steinrueck

Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The Perioperative Angiogenic Balance Is Sensitive to Systemic Thrombospondin-1 Levels

T. Gruenberger, S. Roka, B. Gruenberger, 2008, Clinical Cancer Research.

NeoadjuvantTreatment of Colorectal Cancer with Bevacizumab : The PerioperativeAngiogenic Balance Is Sensitive to SystemicThrombospondin-1 Levels

S. Roka, B. Gruenberger, C. Brostjan, 2008 .